Manufacture Small Molecules, Trends & Forecasts

Innovation in oligonucleotide manufacture

05/31/2023

sponsored by Cytiva

The growth in oligonucleotide therapeutics presents many challenges and opportunities for the manufacture of oligonucleotides, including capacity, scale, sustainability and cost.

Current manufacturing approaches rely on solid support-based synthesis, but the development of a range of alternative technologies offers opportunities to address some of the limitations of solid phase synthesis, but also create some new challenges.

Here, CPI will discuss its collaborative programs (Grand Challenges) and how they look to address these challenges.

Webinar Learning Objectives:

A better understanding of current and future oligo manufacturing processes
How sustainability and other challenges are driving development in this area
A route to form collaborative programs to participate in this and future challenge areas

View On-Demand

Email*

Choose a password

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.